Nyrada Inc is a new pharmaceutical company based in Australia, focused on drug discovery and development for cardiovascular and neurology conditions. The company is focused on tackling diseases and conditions that affect a large number of individuals, where current treatment options are inadequate or non-existent. Nyrada's clinical targets reflect significant community needs, and the company is poised to make a significant impact in the healthcare industry, particularly in the areas of cardiovascular and neurology.